Clinical Trials Directory

Trials / Completed

CompletedNCT01959074

The Effect of Naftopidil for the Double-J Stent Discomfort

The Effect of Naftopidil for the Double-J Stent Discomfort: Multicenter, Randomized, Double-blind, Placebo Controlled Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study is To confirm the efficacy of Naftopidil for reducing discomfort of ureteral stent after urinary stone surgery.

Detailed description

1. Enrollment 1. patients underwent Double-J ureteral stent indwelling after urological surgery during less than 15 days 2. patients aged more than 20 years 2. Randomization 1. naftopidil 75 mg qd or placebo until Double-J stent removal 2. Standard treatment with pain-killers on demand were also applied.(aceclofenac) 3. Follow-up to the day of Double-J stent removal (Evaluation should be done at stent removal)

Conditions

Interventions

TypeNameDescription
DRUGNaftopidilNaftopidil 75mg 1T qd hs
DRUGPlacebo for NaftopidilPlacebo 1T qd hs
DRUGStandard treatmentaceclofenac 100mg on demand

Timeline

Start date
2014-05-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-10-09
Last updated
2015-12-10

Locations

6 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01959074. Inclusion in this directory is not an endorsement.